SENS Foundation logo

SENS Foundation

North America, California, United States, Mountain View

Description

SENS Research Foundation is focused on research and development regenerative medicine for age-related diseases.

Investor Profile

SENS Foundation has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (67%)
  • Pre Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SENS Foundation frequently co-invest with?

Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 1
Helios Capital
North America, New York, United States, New York
Co-Investments: 1
Thynk Capital
North America, Nevada, United States, Las Vegas
Co-Investments: 1
Grapeseed.Bio
North America, New York, United States, La Fayette
Co-Investments: 1
KIZOO Technology Capital
Europe, Baden-Wurttemberg, Germany, Karlsruhe
Co-Investments: 1

Which angels does SENS Foundation often collaborate with?

JM
Europe, Isle of Man
Shared Deals: 2
KA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by SENS Foundation?

OncoSenX

Seattle, Washington, United States

OncoSenX is a developer of transient gene therapies designed for solid tumors.

BiotechnologyHealth Care
Pre SeedApr 1, 2020
Amount Raised: $4,500,000
Repair Biotechnologies

Syracuse, New York, United States

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.

BiotechnologyHealth CareMedical
SeedMay 7, 2019
Amount Raised: $2,150,000
Antoxerene

Lafayette, Louisiana, United States

Antoxerene, Inc. is a pharmaceutical company

BiotechnologyHealth CarePharmaceutical
SeedAug 28, 2017
Amount Raised: $1,500,000